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Introduction
Gliomas are the most common malignant primary brain tumors in adults and exhibit a spectrum of aberrantly aggressive phenotype. Despite advances in treatments during past decades, prognosis of the disease remains poor, with the median survival time approximately 12-14 months. The extremely poor prognosis of patients with gliomas is largely due to the high tendency of tumor invasiveness, which leads to severe structural and functional damage to the surrounding brain tissue, incomplete surgical resection and high frequency of tumor recurrence (1) . The molecular mechanisms underlying the aggressive malignant phenotype of glioma cells, however, remain largely unknown.
It has been established that glioma cells, or their subpopulations, share similar biological phenotype and gene expression profiles to those of neural stem cells (2, 3) . Two common phenotypic features shared by glioma cells and neural stem cells are their robust abilities to migrate through brain parenchyma (4, 5) and to self-renewal (6, 7) . For neural stem cells, these characters typical of cellular "stemness" are essential for tissue homeostasis, regeneration and repairing processes in the central nervous system (CNS). In malignant gliomas, however, these properties contribute to tumor invasiveness. Understanding whether there are common factors that simultaneously modulate the malignant phenotypes of glioma cells and the stemness of neural stem cells is expected to provide new insights in developing novel and effective therapies for glioma. In this context, identification of genetic and/or epigenetic factors that modulate the "stemness" phenotype of glioma cells is of great importance.
Deregulation of miRNAs has been implicated in the development and progression of nearly all tumor types (8) . miRNAs play pivotal roles in development, particularly in modulating stem cell-specific pathways (9) . This prompted us to identify and study miRNAs with Glioma cell lines, including LN443, LN444,   LN464, U118MG, T98G, U251MG, U87MG, D247MG, A172, LN319, LN382T, LN229, LNZ-308 and SNB19, were shared with Dr. Shi-Yuan Cheng's laboratory at Northwestern University, Chicago, IL and cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (HyClone, Logan, UT) as previously described (10, 11) . All cell lines were authenticated by short tandem repeat fingerprinting at IDEXX RADIL (Columbia, MO, USA) and Services at SYSU Forensic Medicine Lab (Guang Zhou China). of SOX4 and EphB2 genes generated by PCR were cloned into retroviral vector pMSCV-neo (Clontech, Palo Alto, CA). Retroviral production and infection were performed as previously described (10 
Results

miR-204 was down-regulated in gliomas
To identify miRNAs with similar expression patterns in glioma and neural stem cells, we retrieved miRNA expression profiles from two datasets, The Cancer Genome Atlas (TCGA) and the GEO dataset GSE29759. As shown in Fig.1A , miR-204 emerged as one of the most prominent down-regulated miRNAs in the TCGA glioblastoma (GBM) dataset, accompanied by several other down-regulated miRNAs reported previously, namely, miR-124 ,106a, 17-5p and members of the miR-181 family (15, 16) . As documented previously, miRNAs up-regulated in gliomas, including miR-21 (17) (18) (19) , miR-9 (20, 21) and miR-10b, were also screened out. (22, 23) . Comparing the miRNA profiles in the TCGA dataset with those in neural stem cells identified that miR-204 was down-regulated in both glioma and neural stem cells ( (Fig. 1D ).
Restoration of miR-204 in glioma cells suppressed cellular migration and invasion
To investigate whether miR-204 could modulate the migration and invasiveness of glioma Importantly, the three-dimensional spheroid invasion assay showed that vector-control cells displayed a highly aggressively penetrating growth after 5 days, whereas the miR-204 transduced-cells grew in spherical colonies (Fig. 2E) . Taken together, these observations suggested that miR-204 strongly inhibited the migration and invasion of glioma cells.
miR-204 attenuated stem cell like phenotype of glioma cells
Malignant gliomas tend to relapse after surgical resection, and that such a character is believed to be largely attributable to the stem cell-like properties of a fraction of cells within a glioma tumor (2) . Since miR-204 is expressed at very low levels in both glioma and neural stem cells but at high levels in differentiated normal brain tissues, we determined the potential role of mir-R-204 in the development and maintenance of the stem-like property of glioma cells. Sphere forming assay showed ( (Fig. 3C) . In further experiments we co-stained for a glioma stem cell marker, Nestin, and an astrocyte differentiation marker, GFAP, during the process of differentiation. We observed a significantly faster decrease of Nestin and simultaneous increase of GFAP expression in cells transduced with miR-204 as compared with those in control cells (Fig. 3D) . Taken together, these data showed that re-introduction of miR-204 in glioma cells reduced the stem cell-like population in glioma and greatly attenuated the ability of stem cell-like glioma cells to retain stemness. (Fig. 5B) . Furthermore, in the above described in vivo glioma model, lower levels of SOX4 and EphB2 staining were detected in tumors formed by miR-204 transduced cells, as compared those in the control tumors (Fig. S2) .
Reintroduction of miR-204 induced loss of invasion and tumorigenecity in vivo
To determine whether inhibition of miR-204 on SOX4 and EphB2 expression is mediated by posttranscriptional effects on the 3'UTRs of both genes, we constructed luciferase reporter plasmid containing 3'UTRs for SOX4 and EphB2, respectively. As shown in Fig. 5C , ectopic expression of miR-204 markedly decreased, while inhibition of miR-204 significantly elevated, the reporter luciferase activities (Fig. 5C ), suggesting that miR-204 post-transcriptionally inhibited SOX4 and EphB2 expression. Furthermore, mutagenesis in miR-204 target sites of the SOX4 or EphB2 3'UTR linked to the luciferase reporter confirmed the site-specific effect of miR-204 (Fig. 5C ). To examine the interaction between miR-204-containing miRNP and target mRNAs, we pulled down Ago1 and its associated RNA in cells transfected by control miRNA or the miR-204 mimic. qPCR assessment of the SOX4 and EphB2 3'UTR regions revealed high levels of SOX4 and EphB2 transcripts enrichment in the miRNP of miR-204 mimic-transfected cells, strongly suggesting that miR-204 could guide miRNP to target SOX4 and EphB2 (Fig. 5D) . Finally, we assessed the expression of SOX4 and EphB2 in 20 glioma specimens shown in Figure 1C , and found significant inverse correlation between miR-204 and its two targets (Fig. S3) . This (Fig. 5F ). Taken together, these data revealed that by coordinately suppressing core regulators of glioma stemness and migration, miR-204 conferred the abilities of self-renewal and invasion in glioma cells.
Hypermethylation in the promoter region of miR-204 gene
We next sought to investigate the molecular mechanism that mediates the down-regulation of miR-204 in glioma cells. Interestingly, miR-204 was an intronic miRNA located between exons 7 and 8 of the TRPM3 gene (30) . Consistent with a previous report (30) , expression of mature miR-204 and pri-miR-204 linearly correlated with that of TRPM3 in NHA and several glioma cell lines (Fig. 6A) , indicating that miR-204 and TRPM3 might share common regulatory mechanism(s). To examine the epigenetic modification of this shared promoter region, we retrieved the CpG-rich loci of TRPM3 promoter from the UCSC genome browser (Fig. 6B) and assessed for their methylation status via bisulfite genomic-sequencing PCR (BSP). The BSP result showed that in NHA, as well as in glioma cells with relatively higher levels of miR-204 expression, the CpG islands were mostly not methylated (Fig. 6C) . By contrast, in genomic DNA obtained from glioma cells with down-regulated miR-204 and from clinical glioma tumor samples, the promoter CpG islands of miR-204 were hypermethylated in most glioma specimens, strongly suggesting an essential role of promoter methylation in miR-204 down-regulation (Fig. 6C and Fig. S4 Accumulated evidence supports the notion that such a process is regulated by signaling pathways similar to those governing the stemness of neural stem cells. Of note, activation of these pathways requires coordinated expression and cooperative action of several core regulators. For example, SOX4 has recently been identified as a determinant factor of glioma stemness, which forms a complex with OCT4 and subsequently activates the transcription of SOX2, one of the core pluripotency reprogramming factors (24, 32) . This transcriptional axis is essential for the maintenance of glioma stem cell population, and more importantly, blocking this pathway greatly improves animal survival in a glioma xenograft model (24) . As a short half-life (<1h) protein (33), the expression level of SOX4 is tightly controlled transcriptionally and post-transcriptionally. In endometrial cancer, down-regulation of miR-129-2 mediates the overexpression of SOX4, suggesting a significance of miRNA-mediated regulation in sustaining the expression of this stemness-associated oncoprotein (34) . In glioma cells, however, the level of miR-129 has not been reported or screened out in high throughput assays to have significant change. In this study, we identified miR-204 as a miRNA commonly down-regulated in both types of 
glioma cell population in which marked stemness is developed. . In miR-204 transduced cells, ectopic expression of SOX4 is able to rescue neural sphere formation ability attenuated by miR-204, confirming that SOX4 is a major target of miR-204 and responsible for maintaining the stem cell population in human gliomas. Of note, miR-204 not only suppresses self-renewal but also migration of glioma cells, which is another hallmark of neural stem cells (5) . This study has also identified EphB2 as a major migration regulator directly targeted by miR-204. Previously, EphB2 has been reported to promote stem cell migration in both physiological and injury repairing conditions (5, 26) . Elevated expression and enhanced phosphorylation of EphB2 has also been found in glioma cells (29, 35) . More Owing to the multi-target property and the network effect, miRNAs is of great importance in the suppression of pluripotency of embryonic stem cells by targeting reprogramming factors and initiating differentiation (9) . During the process of differentiation, an optimal miRNA expression pattern enables proper development of the organism (36) . In tumor cells, however, many of the stem cell-specific miRNA expression patterns are re-archived, such as the loss of neural specific miR-124 expression that promotes the stemness of glioma (15, 37) .
Consistently, we find that miR-204, which is down regulated and thereby expected to play Lastly, we showed that reduction of miR-204 is attributed to down-regulated transcription due to methylation of the promoter of it host gene TRPM3. TRPM3 is a member of the transient receptor potential melastatin (TRPM) family that has been reported to be associated with cancer progression. Down-regulation of TRPM1/melastatin mRNA in the primary cutaneous tumor is a prognostic marker for metastasis in patients with localized malignant melanoma (38) . Moreover, TRPM8 is lost in prostate cancer tissues from patients treated pre-operatively with anti-androgen therapy, suggesting that loss of TRPM8 is associated with a more advanced form of the disease (39) . Despite these findings, however, the pathobiological role of TRPM3 in cancer remains largely unknown. In this context, our current finding that the promoter of TRPM3 is hypermethylated and TRPM3 mRNA is 
